1-4 of 4
Manuela Lemoine, PhD
Close
Sort by
Journal Articles

NVP-BEZ235, A Dual Inhibitor of Phosphoinositol-3-Kinase (PI3K) and Mammalian Target of Rapamycin (mTOR), Is a Potent Inhibitor of Lymphoma Cell Growth and Survival

Daniela Buglio, MD, PhD, Manuela Lemoine, PhD, Sattva S. Neelapu, MD, Francisco Vega, MD, PhD, Donald Berry, Anas Younes, MD
Journal: Blood
Blood (2011) 118 (21): 4965.
https://doi.org/10.1182/blood.V118.21.4965.4965
Published: 2011
Journal Articles

The Small Molecule JAK1/JAK2 Inhibitor INCB16562 Shows Single Agent Activity and Strongly Synergizes with Bcl-2 Inhibitors in Lymphoma

Enrico Derenzini, MD, Manuela Lemoine, PhD, Elisa Brighenti, PhD, Richard Eric Davis, MD, Pier Luigi Zinzani, MD, Anas Younes, MD
Journal: Blood
Blood (2011) 118 (21): 2731.
https://doi.org/10.1182/blood.V118.21.2731.2731
Published: 2011
Journal Articles

The Allosteric AKT Inhibitor MK-2206 Demonstrates Potent Antiproliferative Activity in Lymphoma Cells and Synergizes with the HDAC Inhibitor Vorinostat,

Daniela Buglio, MD, PhD, Manuela Lemoine, PhD, Jaymie Estrella, PhD, Sattva S. Neelapu, MD, Richard Eric Davis, MD, Laurence Doyle, MD, Richard F Little, MD, MPH, Donald Berry, Anas Younes, MD
Journal: Blood
Blood (2011) 118 (21): 3729.
https://doi.org/10.1182/blood.V118.21.3729.3729
Published: 2011
Journal Articles

The Pan-Deacetylase Inhibitor Panobinostat Downregulates HIF-1α and VEGF and, Synergizes with Everolimus In Hodgkin Lymphoma Cell Lines

Manuela Lemoine, PhD, Daniela Buglio, MD, PhD, Adam Jona, Enrico Derenzini, MD, L. Jeffrey Medeiros, MD, Donald A Berry, PhD, Anas Younes, MD
Journal: Blood
Blood (2010) 116 (21): 2851.
https://doi.org/10.1182/blood.V116.21.2851.2851
Published: 2010